1. Home
  2. PSTX vs GHLD Comparison

PSTX vs GHLD Comparison

Compare PSTX & GHLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTX
  • GHLD
  • Stock Information
  • Founded
  • PSTX 2014
  • GHLD 1960
  • Country
  • PSTX United States
  • GHLD United States
  • Employees
  • PSTX N/A
  • GHLD N/A
  • Industry
  • PSTX Biotechnology: Biological Products (No Diagnostic Substances)
  • GHLD Finance: Consumer Services
  • Sector
  • PSTX Health Care
  • GHLD Finance
  • Exchange
  • PSTX Nasdaq
  • GHLD Nasdaq
  • Market Cap
  • PSTX 909.4M
  • GHLD 831.7M
  • IPO Year
  • PSTX 2020
  • GHLD 2020
  • Fundamental
  • Price
  • PSTX $9.45
  • GHLD $14.04
  • Analyst Decision
  • PSTX Hold
  • GHLD Buy
  • Analyst Count
  • PSTX 3
  • GHLD 5
  • Target Price
  • PSTX $9.00
  • GHLD $16.30
  • AVG Volume (30 Days)
  • PSTX 2.7M
  • GHLD 12.5K
  • Earning Date
  • PSTX 11-07-2024
  • GHLD 11-06-2024
  • Dividend Yield
  • PSTX N/A
  • GHLD 3.55%
  • EPS Growth
  • PSTX N/A
  • GHLD N/A
  • EPS
  • PSTX N/A
  • GHLD N/A
  • Revenue
  • PSTX $150,858,000.00
  • GHLD $829,864,000.00
  • Revenue This Year
  • PSTX $131.92
  • GHLD $37.55
  • Revenue Next Year
  • PSTX N/A
  • GHLD $29.77
  • P/E Ratio
  • PSTX N/A
  • GHLD N/A
  • Revenue Growth
  • PSTX 203.18
  • GHLD 4.51
  • 52 Week Low
  • PSTX $1.87
  • GHLD $12.78
  • 52 Week High
  • PSTX $9.58
  • GHLD $18.26
  • Technical
  • Relative Strength Index (RSI)
  • PSTX 86.05
  • GHLD 57.49
  • Support Level
  • PSTX $9.35
  • GHLD $13.63
  • Resistance Level
  • PSTX $9.56
  • GHLD $13.98
  • Average True Range (ATR)
  • PSTX 0.10
  • GHLD 0.36
  • MACD
  • PSTX -0.17
  • GHLD 0.08
  • Stochastic Oscillator
  • PSTX 56.67
  • GHLD 71.82

About PSTX Poseida Therapeutics Inc.

Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.

About GHLD Guild Holdings Company

Guild Holdings Co is a growth-oriented mortgage company. It operates in two segments; The origination segment operates its loan origination business throughout the United States. It is responsible for loan origination, acquisition, and sale activities. This segment is further divided into retail and correspondent channel, and The servicing segment provides a steady stream of cash flow to support the origination segment more importantly it allows for the Company to build long-standing client relationships that drive repeat and referral business back to the origination segment to recapture the client's next mortgage transaction. It is responsible for the servicing activities of all loans in its servicing portfolio. It generates a majority of its revenue from the Origination segment.

Share on Social Networks: